Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Coins2Day 500
Coins2Day 500 U.S.
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Coins2Day 500
Coins2Day 500
Coins2Day 500 U.S.
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Biotech
Biotech
Page 2 of 19
Life
This company is launching a genetic matching feature for future parents—and the CEO says ‘it has nothing to do with eugenics’
By
Alexa Mikhail
March 23, 2025
Commentary
My son’s rare disease diagnosis spurred me to ditch Big Pharma for a biotech startup
By
Michelle Werner
March 10, 2025
Leadership
A few years ago 23andMe was worth $6 billion. Now CEO Anne Wojcicki is trying to buy it back for $42 million
By
Lila MacLellan
March 1, 2025
Finance
Investors are plunking billions of dollars into AI-focused biopharma companies—a more than 300% increase from 2023
By
Healthcare Brew
and
Maia Anderson
January 31, 2025
Health
Sam Altman-backed AI biotech announces $1 billion for its lofty goal: adding 10 years to human life span
By
Beth Greenfield
January 24, 2025
Health
Pharma giant Regeneron is spending $119.5M on the world’s largest, most diverse genetic database using DNA from patient volunteers
By
Lindsey Leake
January 16, 2025
Tech
Merck snags Chinese obesity drug in nearly $2 billion deal
By
Robert Langreth
and
Bloomberg
December 19, 2024
Arnold Schwarzenegger is joining a Coins2Day 500 company to solve a great problem of his generation
By
Lindsey Leake
November 13, 2024
Leadership
23andMe’s entire board resigned on the same day. Founder Anne Wojcicki still thinks the startup is savable
By
Lila MacLellan
October 17, 2024
Will you live to 150? Here’s what 5 geneticists and aging researchers say
By
Alexa Mikhail
October 6, 2024
Health
How to delete your DNA data from 23andMe
By
Alexa Mikhail
October 5, 2024
Health
Free, at-home COVID tests are back. Here’s how to order yours
By
Lindsey Leake
September 24, 2024
Environment
California firm grows cocoa from cell cultures as climate change threatens supply
By
Amy Taxin
,
Terry Chea
and
The Associated Press
September 1, 2024
Health
Sergey Brin is using money from selling his Tesla shares to bankroll a startup developing hallucinogenic mental-health treatments
By
Marco Quiroz-Gutierrez
July 23, 2024
Newsletters
Exclusive: Holoclara raises $16 million Series A to develop therapeutics—with worms
By
Allie Garfinkle
June 27, 2024
Most Popular
AI
This CEO laid off nearly 80% of his staff because they refused to adopt AI fast enough. 2 years later, he says he'd do...
By
Nick Lichtenberg
Economy
A Supreme Court ruling that strikes down Trump's tariffs would be the fastest way to revive the stalling job market,...
By
Jason Ma
Economy
Trump may be raising your taxes with his tariffs but he could actually cut inflation with them, too, SF Fed says
By
Jake Angelo